Brendon Neuen
@brendonneuen
Nephrologist, Associate Professor, Director of Kidney Trials, Royal North Shore Hospital | @NHMRC @GeorgeInstitute Fellow | Secretariat, SMART-C
ID: 25062503
18-03-2009 12:14:59
6,6K Tweet
4,4K Takipçi
1,1K Takip Edilen
Matt Weir & I offer an obituary of our affable colleage George Bakris ahajournals.org/doi/abs/10.116… "With a diagnosis of cancer 4 years ago, pain was inevitable. But how to respond to this crisis was a choice. Dr Bakris inspired us by publishing >200 papers while battling his disease."
Being presented at #ESCCongress ⬇️ Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis hubs.li/Q02M1wzF0 European Society of Cardiology
Led by #JawadButt, our analysis of drug effects on kidney endpoints in 6 large-scale placebo-controlled trials in HF is now in Circulation Important for interpreting the observed effects of finerenone on the secondary kidney outcome in FINEARTS-HF #ESCCongress Muthu Vaduganathan
Why Has it Been Challenging to Modify CKD Progression in Heart Failure? Our #simpub special communication in JACC Journals: - Slower rate of progression - Acute effects on GFR - Shorter follow-up - Competing/intercurrent events #ESCCongress sciencedirect.com/science/articl…
From #ESCCongress: We spoke with Brendon Neuen about the results of a systematic review & meta-analysis examining the effects of combination therapy with GLP-1 RAs & SGLT2i on CV & kidney outcomes among patients with T2D. hcplive.com/view/brendon-n… #NephTwitter #Cardiology
Great work from Hannah Wallace who is leading a suite of projects to better understand gaps in CKD care using routinely collected data in Aus Major opportunities for improved implementation of proven therapies to reduce the burden of kidney failure #ANZSN2024
Whole pop UK linked data on >230,000 ppl with HF from Robert Fletcher at #ESCCongress - Ppl with CKD remain undertreated for HF despite being at 🔼 risk - CKD contributes 2x to 🏥/☠️ than any other comorbidity - Major opportunities to improve pop health In press, The Lancet Public Health
Congratulations Robert, Brendon Neuen and the rest of the team for producing this impactful work in the The Lancet Public Health showing utility of electronic data capturing quality of care and trajectory of multi morbid patients. British Heart Foundation data science centre key in creating environments for
What an incredible #ESCCongress - so much fantastic and practice changing science Our The George Institute for Global Health/Brigham and Women's Hospital Harvard Medical School publications on the intersection of heart failure & CKD featured in Nature Medicine, Circulation, JACC Journals, and The Lancet Public Health
Can't get enough of FINEARTS-HF or maybe you're wondering what it means for spironolactone? Check out the latest episode of #DontMissABeat where Muthu Vaduganathan and Steve Greene break down the trial, results, and future research priorities. hcplive.com/view/dont-miss… #ESCCongress
Yes agree, Graham Abra, MD - Effects of finerenone in non-diabetic CKD being evaluated in FIND-CKD N=1584 57% GN (417 with IgAN) PEP= total slope over 3 years SEP= 57%⬇️ eGFR, ESKD or renal death Median UACR=819mg/g 17% SGLT2i use at baseline academic.oup.com/ndt/advance-ar…
Our review on the pathogenesis of IgA nephropathy and implications for treatment, out now in Nature Reviews Nephrology Nature Reviews Nephrology. Link to the full text here: rdcu.be/dSXxz Suceena Alexander Haresh Selvaskandan Jonathan Barratt
